肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

癌症的内吞作用和癌症治疗

Endocytosis in cancer and cancer therapy

原文发布日期:2023-05-22

DOI: 10.1038/s41568-023-00574-6

类型: Review Article

开放获取: 否

英文摘要:

摘要翻译: 

原文链接:

文章:

癌症的内吞作用和癌症治疗

Endocytosis in cancer and cancer therapy

原文发布日期:2023-05-22

DOI: 10.1038/s41568-023-00574-6

类型: Review Article

开放获取: 否

 

英文摘要:

Endocytosis is a complex process whereby cell surface proteins, lipids and fluid from the extracellular environment are packaged, sorted and internalized into cells. Endocytosis is also a mechanism of drug internalization into cells. There are multiple routes of endocytosis that determine the fate of molecules, from degradation in the lysosomes to recycling back to the plasma membrane. The overall rates of endocytosis and temporal regulation of molecules transiting through endocytic pathways are also intricately linked with signalling outcomes. This process relies on an array of factors, such as intrinsic amino acid motifs and post-translational modifications. Endocytosis is frequently disrupted in cancer. These disruptions lead to inappropriate retention of receptor tyrosine kinases on the tumour cell membrane, changes in the recycling of oncogenic molecules, defective signalling feedback loops and loss of cell polarity. In the past decade, endocytosis has emerged as a pivotal regulator of nutrient scavenging, response to and regulation of immune surveillance and tumour immune evasion, tumour metastasis and therapeutic drug delivery. This Review summarizes and integrates these advances into the understanding of endocytosis in cancer. The potential to regulate these pathways in the clinic to improve cancer therapy is also discussed.

 

摘要翻译: 

内吞作用是一个复杂的过程,细胞通过该过程将细胞表面蛋白、脂质及细胞外环境的液体进行包装、分选并内化至细胞内。内吞作用也是药物内化进入细胞的机制之一。多种内吞途径决定了分子的最终命运——从在溶酶体中降解到再循环至质膜。内吞的整体速率及其通路中分子转运的时间调控也与信号传导结果密切相关。这一过程依赖于一系列因素,如内在氨基酸基序和翻译后修饰。内吞作用在癌症中常发生紊乱,导致受体酪氨酸激酶异常滞留于肿瘤细胞膜、致癌分子循环改变、信号反馈环路缺陷以及细胞极性丧失。过去十年间,内吞作用已被揭示在营养摄取、免疫监视的响应与调控、肿瘤免疫逃逸、肿瘤转移及治疗性药物递送中发挥关键调节作用。本综述总结并整合这些进展以深化对癌症中内吞作用的理解,同时探讨在临床中调控这些通路以改善癌症治疗的潜力。

 

原文链接:

Endocytosis in cancer and cancer therapy

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……